# Enact Holdings, Inc.: financial statements, quarterly

ACT · Nasdaq · CIK 1823529 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/act.md) · [Financials](/companies/act/financials.md) · [Filings](/companies/act/filings.md) · [Insiders](/companies/act/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/act/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [299](/filings/0001823529-24-000211.md) | [296 d](/filings/0001823529-26-000060.md) | [292](/filings/0001823529-25-000124.md) | [299](/filings/0001823529-25-000187.md) | [310](/filings/0001823529-25-000227.md) | [302 d](/filings/0001823529-26-000060.md) | [307](/filings/0001823529-26-000109.md) | [305](/filings/0001823529-26-000188.md) | [311](/filings/0001823529-25-000227.md) | [313 d](/filings/0001823529-26-000060.md) | [312](/filings/0001823529-26-000109.md) | [317](/filings/0001823529-26-000188.md) |
| Interest expense | $m | [12.9](/filings/0001823529-24-000211.md) | [12.9 d](/filings/0001823529-26-000060.md) | [13.0](/filings/0001823529-25-000124.md) | [13.6](/filings/0001823529-25-000187.md) | [12.3](/filings/0001823529-25-000227.md) | [12.3 d](/filings/0001823529-26-000060.md) | [12.3](/filings/0001823529-26-000109.md) | [12.3](/filings/0001823529-26-000188.md) | [12.9](/filings/0001823529-25-000227.md) | [12.5 d](/filings/0001823529-26-000060.md) | [12.4](/filings/0001823529-26-000109.md) | [12.5](/filings/0001823529-26-000188.md) |
| Income tax | $m | [48.9](/filings/0001823529-24-000211.md) | [42.4 d](/filings/0001823529-26-000060.md) | [44.9](/filings/0001823529-25-000124.md) | [51.2](/filings/0001823529-25-000187.md) | [48.8](/filings/0001823529-25-000227.md) | [45.1 d](/filings/0001823529-26-000060.md) | [45.6](/filings/0001823529-26-000109.md) | [46.7](/filings/0001823529-26-000188.md) | [46.3](/filings/0001823529-25-000227.md) | [45.9 d](/filings/0001823529-26-000060.md) | [45.6](/filings/0001823529-26-000109.md) | [45.1](/filings/0001823529-26-000188.md) |
| Net income | $m | [164](/filings/0001823529-24-000211.md) | [157 d](/filings/0001823529-26-000060.md) | [161](/filings/0001823529-25-000124.md) | [184](/filings/0001823529-25-000187.md) | [181](/filings/0001823529-25-000227.md) | [163 d](/filings/0001823529-26-000060.md) | [166](/filings/0001823529-26-000109.md) | [168](/filings/0001823529-26-000188.md) | [163](/filings/0001823529-25-000227.md) | [177 d](/filings/0001823529-26-000060.md) | [168](/filings/0001823529-26-000109.md) | [175](/filings/0001823529-26-000188.md) |
| Diluted EPS | $ per share | [1.02](/filings/0001823529-24-000211.md) | not reported | [1.01](/filings/0001823529-25-000124.md) | [1.16](/filings/0001823529-25-000187.md) | [1.15](/filings/0001823529-25-000227.md) | not reported | [1.08](/filings/0001823529-26-000109.md) | [1.11](/filings/0001823529-26-000188.md) | [1.10](/filings/0001823529-25-000227.md) | not reported | [1.18](/filings/0001823529-26-000109.md) | [1.25](/filings/0001823529-26-000188.md) |
| Basic EPS | $ per share | [1.03](/filings/0001823529-24-000211.md) | not reported | [1.01](/filings/0001823529-25-000124.md) | [1.17](/filings/0001823529-25-000187.md) | [1.16](/filings/0001823529-25-000227.md) | not reported | [1.09](/filings/0001823529-26-000109.md) | [1.12](/filings/0001823529-26-000188.md) | [1.11](/filings/0001823529-25-000227.md) | not reported | [1.18](/filings/0001823529-26-000109.md) | [1.25](/filings/0001823529-26-000188.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [678](/filings/0001823529-23-000211.md) | [616](/filings/0001823529-25-000070.md) | [614](/filings/0001823529-24-000105.md) | [699](/filings/0001823529-24-000160.md) | [673](/filings/0001823529-24-000211.md) | [599](/filings/0001823529-26-000060.md) | [635](/filings/0001823529-25-000124.md) | [613](/filings/0001823529-25-000187.md) | [544](/filings/0001823529-25-000227.md) | [582](/filings/0001823529-26-000188.md) | [549](/filings/0001823529-26-000109.md) | [448](/filings/0001823529-26-000188.md) |
| Total assets | $m | [6,001](/filings/0001823529-23-000211.md) | [6,190](/filings/0001823529-25-000070.md) | [6,304](/filings/0001823529-24-000105.md) | [6,349](/filings/0001823529-24-000160.md) | [6,597](/filings/0001823529-24-000211.md) | [6,522](/filings/0001823529-26-000060.md) | [6,722](/filings/0001823529-25-000124.md) | [6,773](/filings/0001823529-25-000187.md) | [6,876](/filings/0001823529-25-000227.md) | [6,893](/filings/0001823529-26-000188.md) | [6,962](/filings/0001823529-26-000109.md) | [6,956](/filings/0001823529-26-000188.md) |
| Total liabilities | $m | [1,543](/filings/0001823529-23-000211.md) | [1,558](/filings/0001823529-25-000070.md) | [1,590](/filings/0001823529-24-000105.md) | [1,524](/filings/0001823529-24-000160.md) | [1,561](/filings/0001823529-24-000211.md) | [1,525](/filings/0001823529-26-000060.md) | [1,602](/filings/0001823529-25-000124.md) | [1,550](/filings/0001823529-25-000187.md) | [1,559](/filings/0001823529-25-000227.md) | [1,538](/filings/0001823529-26-000188.md) | [1,618](/filings/0001823529-26-000109.md) | [1,561](/filings/0001823529-26-000188.md) |
| Long-term debt | $m | [745](/filings/0001823529-23-000211.md) | [745](/filings/0001823529-25-000070.md) | [746](/filings/0001823529-24-000105.md) | [742](/filings/0001823529-24-000160.md) | [743](/filings/0001823529-24-000211.md) | [743](/filings/0001823529-26-000060.md) | [743](/filings/0001823529-25-000124.md) | [744](/filings/0001823529-25-000187.md) | [744](/filings/0001823529-25-000227.md) | [744](/filings/0001823529-26-000188.md) | [745](/filings/0001823529-26-000109.md) | [745](/filings/0001823529-26-000188.md) |
| Shareholders' equity | $m | [4,457](/filings/0001823529-24-000211.md) | [4,632](/filings/0001823529-26-000060.md) | [4,714](/filings/0001823529-25-000187.md) | [4,826](/filings/0001823529-25-000227.md) | [5,036](/filings/0001823529-25-000227.md) | [4,996](/filings/0001823529-26-000188.md) | [5,119](/filings/0001823529-26-000188.md) | [5,223](/filings/0001823529-26-000188.md) | [5,317](/filings/0001823529-25-000227.md) | [5,355](/filings/0001823529-26-000188.md) | [5,344](/filings/0001823529-26-000188.md) | [5,396](/filings/0001823529-26-000188.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [155 d](/filings/0001823529-24-000211.md) | [190 d](/filings/0001823529-26-000060.md) | [187](/filings/0001823529-25-000124.md) | [145 d](/filings/0001823529-25-000187.md) | [188 d](/filings/0001823529-25-000227.md) | [166 d](/filings/0001823529-26-000060.md) | [227](/filings/0001823529-26-000109.md) | [120 d](/filings/0001823529-26-000188.md) | [192 d](/filings/0001823529-25-000227.md) | [186 d](/filings/0001823529-26-000060.md) | [224](/filings/0001823529-26-000109.md) | [119 d](/filings/0001823529-26-000188.md) |
| Dividends paid | $m | [25.6 d](/filings/0001823529-24-000211.md) | [139 d](/filings/0001823529-26-000060.md) | [25.5](/filings/0001823529-25-000124.md) | [29.1 d](/filings/0001823529-25-000187.md) | [28.8 d](/filings/0001823529-25-000227.md) | [28.4 d](/filings/0001823529-26-000060.md) | [28.1](/filings/0001823529-26-000109.md) | [31.5 d](/filings/0001823529-26-000188.md) | [31.0 d](/filings/0001823529-25-000227.md) | [30.3 d](/filings/0001823529-26-000060.md) | [29.8](/filings/0001823529-26-000109.md) | [33.5 d](/filings/0001823529-26-000188.md) |
| Share repurchases | $m | [6.3 d](/filings/0001823529-24-000211.md) | [18.0 d](/filings/0001823529-26-000060.md) | [49.7](/filings/0001823529-25-000124.md) | [48.6 d](/filings/0001823529-25-000187.md) | [71.0 d](/filings/0001823529-25-000227.md) | [74.6 d](/filings/0001823529-26-000060.md) | [65.3](/filings/0001823529-26-000109.md) | [84.6 d](/filings/0001823529-26-000188.md) | [106 d](/filings/0001823529-25-000227.md) | [127 d](/filings/0001823529-26-000060.md) | [93.2](/filings/0001823529-26-000109.md) | [93.3 d](/filings/0001823529-26-000188.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [163](/filings/0001823529-23-000211.md) | [163](/filings/0001823529-24-000105.md) | [162](/filings/0001823529-24-000160.md) | [161](/filings/0001823529-24-000211.md) | [160](/filings/0001823529-25-000124.md) | [159](/filings/0001823529-25-000187.md) | [157](/filings/0001823529-25-000227.md) | [153](/filings/0001823529-26-000109.md) | [151](/filings/0001823529-26-000188.md) | [148](/filings/0001823529-25-000227.md) | [143](/filings/0001823529-26-000109.md) | [140](/filings/0001823529-26-000188.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 137,483,671 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001823529-26-000188.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.